BSE filing, NSE: TELECANOR. Summary written from the filing by ALFA Finder's alert engine.
TeleCanor Global Ltd: key numbers
- Share price
- ₹13.61
- Market cap
- ₹22.44 Cr
- Promoter holding
- 34.09%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from TeleCanor Global Ltd
All →TeleCanor Global Other Announcement
TeleCanor Global Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
TeleCanor Global Q1 FY27 Results: Net Loss of ₹0.5 Cr
TeleCanor Global Ltd reported revenue from operations of ₹2.8 Cr (+154.5% YoY) and a net loss of ₹0.5 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.5 Cr
TeleCanor Global Financial Results
TeleCanor Global approved audited financial results for the period ended 31.03.2026. The independent auditor's report has been filed along with the announcement.
TeleCanor Global Other Announcement
TeleCanor discloses its BSE listing application, filed in January 2026, remains pending despite multiple query responses. No new approvals or material business developments are reported.
TeleCanor Global Management Change
TeleCanor Global Ltd's Board approved the process for removing its Statutory Auditor, M/s. K.K. Goel & Co., citing continued non-cooperation.
TeleCanor Global Management Change
TeleCanor Global re-designated MD Praturi Maruti Ram as Non-Executive Director and elevated Swetha Pilli to MD. Statutory auditors K.K. Goel & Co. are also being removed.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.